SCHEMBL5657782

SCHEMBL5657782

CCOc1ccccc1NC(=O)OCCN1CCN(c2cccc(Cl)c2)CC1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.63
MEN1 O00255 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.61
HTR1A P08908 1/20 0.59
HTR7 P34969 1/20 0.59
LMNA P02545 1/20 0.57
TSHR P16473 1/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
MAPT P10636 2/20 0.52
CACNA1G O43497 1/20 0.52
ADORA2B P29275 1/20 0.52
HTR4 Q13639 1/20 0.52
SLC6A2 P23975 1/20 0.51
SLC6A4 P31645 1/20 0.51
NPC1 O15118 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658021 0.94 L3MBTL1 (0.64) KMT2AMEN1L3MBTL1HTR1AHTR7
SCHEMBL5657975 0.91 MAPT (0.59) KMT2AMEN1L3MBTL1HTR1AHTR7
SCHEMBL5656137 0.90 NPC1 (0.51) KMT2AMEN1L3MBTL1HTR1AHTR7
SCHEMBL14457597 0.90 DRD2 (0.52) KMT2AMEN1L3MBTL1HTR1AHTR7
SCHEMBL5655714 0.90 MEN1 (0.74) KMT2AMEN1L3MBTL1LMNATSHR
SCHEMBL5659356 0.90 MAPT (0.58) KMT2AMEN1L3MBTL1LMNATSHR
SCHEMBL5657841 0.90 HTR1A (0.55) KMT2AMEN1HTR1AHTR7LMNA
SCHEMBL5656207 0.89 NPC1 (0.65) KMT2AMEN1L3MBTL1HTR1ALMNA
SCHEMBL6176786 0.89 POLB (0.51) KMT2AMEN1L3MBTL1HTR1AHTR7
SCHEMBL6419494 0.88 POLB (0.50) KMT2AMEN1L3MBTL1HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-7238693-B2 Aryl carbamate derivatives, preparation and use thereof CEREP (FR) 2007-07-03 US disclosed
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof CEREP (FR) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058933-A1 Aryl carbamate derivatives, preperation and use thereof HTR4, HTR5A, HTR3C KMT2A 2124/4885MEN1 3474/4885L3MBTL1 4733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.